| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9418 |
| Human Intestinal Absorption | HIA+ | 0.9725 |
| Caco-2 Permeability | Caco2+ | 0.6261 |
| P-glycoprotein Substrate | Non-substrate | 0.8455 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9786 |
| Non-inhibitor | 0.9781 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9142 |
| Distribution |
| Subcellular localization | Lysosome | 0.5526 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8473 |
| CYP450 2D6 Substrate | Non-substrate | 0.8257 |
| CYP450 3A4 Substrate | Non-substrate | 0.8090 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8748 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8802 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9691 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9372 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9832 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8287 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9621 |
| Non-inhibitor | 0.9639 |
| AMES Toxicity | Non AMES toxic | 0.9194 |
| Carcinogens | Carcinogens | 0.6655 |
| Fish Toxicity | Low FHMT | 0.6285 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7685 |
| Honey Bee Toxicity | High HBT | 0.7757 |
| Biodegradation | Ready biodegradable | 0.5241 |
| Acute Oral Toxicity | III | 0.5606 |
| Carcinogenicity (Three-class) | Non-required | 0.5025 |